Simulation model for comparing the costs and effectiveness of different pneumococcal conjugate vaccines

Procedia in Vaccinology

Volumn 1, Issue 1, 2009, Pages 67-72

  De Wals, Philippe ^a   Poirier, Béatrice ^b   Petit, Geneviève ^b   Erickson, Lonny ^c   Pépin, Jacques ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; HUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SIMULATION;

EID: 71549161735     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2009.07.012     Document Type: Article

References (10)

1. Morrow A., et al. Can J Infect Dis Med Microbiol 18 (2007) 121-127
2. Melegaro A., et al. Vaccine 22 (2004) 4203-4214
3. Boulianne N., et al. Institut national de santé publique du Québec (2007)
4. Eskola J., et al. N Engl J Med 344 (2001) 403-409
5. Black S., et al. Pediatr Infect Dis J 19 (2000) 187-195
6. Fireman B., et al. Pediatr Infect Dis J 22 (2003) 10-16
7. Palmu A., et al. Pediatr Infect Dis J 23 (2004) 732-738
8. Whitney C., et al. Lancet 368 (2006) 1495-1502
9. Prymula R., et al. Lancet 367 (2006) 740-748
10. Black S., et al. Pediatr Infect Dis J 21 (2002) 810-815